Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: There is limited information from large-scale prospective studies regarding the prediction of type 1 diabetes by specific types of pancreatic islet autoantibodies, either alone or in combination. Thus, we studied the extent to which specific autoantibodies are predictive of type 1 diabetes. RESEARCH DESIGN AND METHODS: Two cohorts were derived from the first screening for islet cell autoantibodies (ICAs) in the Diabetes Prevention Trial-Type 1 (DPT-1). Autoantibodies to GAD 65 (GAD65), insulinoma-associated antigen-2 (ICA512), and insulin (micro-IAA [mIAA]) were also measured. Participants were followed for the occurrence of type 1 diabetes. One cohort (Questionnaire) included those who did not enter the DPT-1 trials, but responded to questionnaires (n = 28,507, 2.4% ICA(+)). The other cohort (Trials) included DPT-1 participants (n = 528, 83.3% ICA(+)). RESULTS: In both cohorts autoantibody number was highly predictive of type 1 diabetes (P < 0.001). The Questionnaire cohort was used to assess prediction according to the type of autoantibody. As single autoantibodies, ICA (3.9%), GAD65 (4.4%), and ICA512 (4.6%) were similarly predictive of type 1 diabetes in proportional hazards models (P < 0.001 for all). However, no subjects with mIAA as single autoantibodies developed type 1 diabetes. As second autoantibodies, all except mIAA added significantly (P < 0.001) to the prediction of type 1 diabetes. Within the positive range, GAD65 and ICA autoantibody titers were predictive of type 1 diabetes. CONCLUSIONS: The data indicate that the number of autoantibodies is predictive of type 1 diabetes. However, mIAA is less predictive of type 1 diabetes than other autoantibodies. Autoantibody number, type of autoantibody, and autoantibody titer must be carefully considered in planning prevention trials for type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the risk of type 1 diabetes increases as the number of relevant autoantibodies detected increases (55,74,75).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the risk of type 1 diabetes increases as the number of relevant autoantibodies detected increases (53,74,75).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469 · cited 2×
“The number shown for each curve (1, 2) indicates the number of autoantibodies.”
BackgroundInsulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Self-citationEffects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Termination of Pregnancy on Psychiatric Grounds
(1964) · The Lancet · doi:10.1016/s0140-6736(64)92746-1 · Cited by 681
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Keele, G. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91022-2 · Cited by 499
EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS
Gorsuch, A. N., Lister, J., Dean, B. M., Spencer, K. M., Mcnally, J. M., Bottazzo, G. F., & Cudworth, A. G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92795-1 · Cited by 480
Grubin, C. E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagopian, W. A., Li, L., Karlsen, A. E., Boel, E., Michelsen, B., & Lernmark, �. (1994) · Diabetologia · doi:10.1007/bf00408469 · Cited by 415 · cited 1×
“Labeled recombinant GAD65 and ICA512 autoantibodies were produced by in vitro transcription/ translation with differential labeling ([(3)H]GAD65 and [(35)S]ICA512) (8,13).”
MethodBingley, P. J., Christie, M. R., Bonifacio, E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1304 · Cited by 389
Cited by
Items 201–269 of 269
Epidemiology and risk factors for type 1 diabetes mellitus
Steck, A. K., & Rewers, M. J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch2 · Cited by 6
Vera, F., Jofré, P., Rodríguez, D., Lagos, R., Quiroga, T., Grassi, B. A., & Felipe Pollak, C. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000300330 · Cited by 5
Tandel, D., Hinton, B., Cortez, F. D. J., Seftel, D., Robinson, P. V., & Tsai, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1340436 · Cited by 4
Economic analysis of diabetes type 1 screening in children in the Russian Federation
Nedogoda, S. V., Galstyan, G. R., Лаптев, Д. Н., Salasyuk, A. S., Barykina, I. N., Lutova, V. O., & Popova, E. A. (2024) · Medical Technologies Assessment and Choice · doi:10.17116/medtech202446031104 · Cited by 4
Titovich, E. V., Кураева, Т. Л., Prokof'ev, S. A., Peterkova, V. A., & Dedov, I. I. (2010) · Diabetes Mellitus · doi:10.14341/2072-0351-6051 · Cited by 4
Inflammatory Pathways Linked to Beta Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_30-2 · Cited by 6
Insulin autoimmune syndrome as part of pre-clinical LADA
Sutkowska, E., Ostrowska, M., & Sutkowska, M. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s302874 · Cited by 3
Bombicino, S. S., Trabucchi, A., Sabljic, A. V., Marfía, J. I., Iacono, R. F., & Valdez, S. N. (2025) · European journal of medical research · doi:10.1186/s40001-025-03457-8 · Cited by 3
“The combined presence of these autoantibodies in serum is the best predictive sign of both the loss of immune tolerance and the clinical manifestation of the pathology [25, 26].”
Campa‐Carranza, J. N., Capuani, S., Willman, M. A., Rabassa, A., Joubert, A. L., Bo, T., Franco, L., Conte, M., Anaya‐García, A. L., Rome, G. E., et al. (2026) · Advanced Science · doi:10.1002/advs.202520914 · Cited by 3
“B cell infiltration increased by 37%–138% at later timepoints, raising concern given the role of antibody-mediated rejection in T1D [ 70 ].”
Biomarkers and their Clinical Applications in Pediatrics
Elgörmüş, Y. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040463122010019 · Cited by 3
Melanitou, E., Tekaia, F., & Yeramian, E. (2012) · Gene · doi:10.1016/j.gene.2012.09.055 · Cited by 3
Skyler, J. S. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_15-1 · Cited by 4
Self-citationShah, V. N., & Yu, L. (2015) · Diabetes Care · doi:10.2337/dc14-2575 · Cited by 3
Self-citationDeletion of Ptpn2 in B cells promotes autoimmunity via TLR and JAK/STAT signaling
Alexander, B. N., Kim, S., Wells, K. L., Hunter, M. J., Toole, K. P., Wemlinger, S. M., Regan, D. P., Getahun, A., & Smith, M. J. (2025) · JCI Insight · doi:10.1172/jci.insight.196144 · Cited by 2
IN DEBATE: THE PRIMARY CAUSE OF TYPE 1 DIABETES
Ionescu-Tirgoviste, C., Guja, C., Gagniuc, P. A., Davila, C., & Paulescu, N. (2014) · Cited by 2
Zhao, Z., Gu, Y., Cheng, J., & Yu, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75515 · Cited by 2
Self-citationQi, Y., Chen, S., Chen, H., Chen, Y., Shi, Y., Yao, Q., Zhang, M., Yang, T., & Gu, Y. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac720 · Cited by 2
Tallon, E. M., & Dreisbach, C. (2019) · Biological Research For Nursing · doi:10.1177/1099800419863161 · Cited by 2
Role of Micronutrients and Trace Elements in Diabetes Mellitus: A Review
Amar, G., & Manickamoorthi, N. (2021) · Springer eBooks · doi:10.1007/978-981-15-8791-7_17 · Cited by 2
Nandedkar-Kulkarni, N., Esakov, E. L., Gregg, B. E., Atkinson, M. A., Rogers, D. G., Horner, J. D., Singer, K., Lundy, S. K., Felton, J. L., Al-Huniti, T., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.1900357 · Cited by 2
“Specifically, high risk relatives of individuals with T1D with two autoantibodies were demonstrated to have a 25% 5-year risk of developing T1D, while those with three autoantibodies had a risk of 40% 5-year risk, and those with four autoantibodies had a 50% 5-year risk in the diabetes prevention Trial-1 (DPT-1) (62).”
BackgroundCollin, R., Dugas, V., Pelletier, A., Chabot‐Roy, G., & Lesage, S. (2021) · Immunogenetics · doi:10.1007/s00251-021-01214-9 · Cited by 2
Leão, I. S., Araújo, D. B., Barone, B., Dantas, J. R., NOLASCO, M., Soares, M. O., Kendler, D. B., Kupfer, R., Zajdenverg, L., & Rodacki, M. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000370 · Cited by 2
Diagnosis of Diabetes Mellitus
Dods, R. F. (2013) · Wiley eBooks · doi:10.1002/9781118530665.ch7 · Cited by 2
Stiff limb syndrome, first case report in Palestine
Hammad, M., Alhroub, W., Amro, A. M., Rije, R. F., Saif, M. A., & Abo-Ghosh, M. (2025) · Neuroimmunology Reports · doi:10.1016/j.nerep.2025.100259 · Cited by 1
Ohnishi, M., Anno, T., Takahashi, K., Okauchi, S., Murakami, K., Kaku, K., Kaneto, H., & Kamei, S. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5567-25 · Cited by 2
“The greater the number of islet-associated autoantibodies, the more likely an individual is to be at risk of developing T1DM (9).”
Pugliese, A., Campbell‐Thompson, M., Staeva, T. P., & Atkinson, M. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4051-2_24 · Cited by 1
Beta-cell regeneration in human pancreas: the lessons of pancreatic pathology.
Maulis, M. F., & Gianani, R. (2012) · PubMed · Cited by 1
Tolerance and Autoimmunity in Type 1 Diabetes
Caro, V. D., Giannoukakis, N., & Trucco, M. (2011) · InTech eBooks · doi:10.5772/20651 · Cited by 2
“A recent phase I study using a single intramuscular injection of human insulin B chain in incomplete Freund’s adjuvant in 12 subjects with recent-onset diabetes showed that this therapy led to the development of lasting (at a 2 year follow-up) insulin B chain-specific Tregs (Orban et al., 2009).”
Neuroimmune Mechanisms in Autism
Miller, V. M., Racine, R., & Zalcman, S. S. (2013) · Wiley eBooks · doi:10.1002/9781118314814.ch22 · Cited by 2
Molecular-genetic, immunological bases and prophylaxis of diabetes mellitus in children
Титович, Е. В. (2011) · Problems of Endocrinology · doi:10.14341/probl20115719-18 · Cited by 1
Burek, C. L., Rose, N. R., Barbesino, G., Wang, J., Steck, A. K., Eisenbarth, G. S., Yu, L., Vincentiis, L. D., Ricciuti, A., Remigis, A. D., et al. (2016) · ASM Press eBooks · doi:10.1128/9781555818722.ch98 · Cited by 1
Self-citationRodelo‐Haad, C., Agüera, M. L., Carmona, A., Navarro, M. D., Carracedo, J., Rodríguez‐Benot, A., & Aljama, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212547 · Cited by 1
Tronko, M. D., Mankovskyi, B., & Попова, В. В. (2019) · JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE · doi:10.37621/jnamsu-2019-3-285-295 · Cited by 1
β-Cell Regeneration in Human Pancreas: The Lessons of Pancreatic Pathology
Maulis, M. F., & Gianani, R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_23 · Cited by 1
Hall, C. A. (2013) · Digital Commons - University of South Florida (University of South Florida)
Arns, T. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2013.tde-02032013-103306
Statistical Methods on Emerging Medical Studies.
Hu, Y. (2012) · Deep Blue (University of Michigan)
Hafidh, K., & Abbas, S. (2014) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/1947-489x.210383
Approaches for Imaging Pancreatic Islets: Recent Advances and Future Prospects
Montet, X., Lamprianou, S., Vinet, L., Meda, P., & Fort, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_39
The Predictive Value of Biopsy of the Pancreas and Its Therapeutic Impact in Autoimmune Diabetes
Nassar, W., & Mostafa, M. A. (2014) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2014.44041
“For T1DM prediction, a combination of GAD65 and IA-2 for primary screening, followed by ICA and IAA testing, has been proposed [11].”
Methodvan Heiningen, J., Keij, F. M., & Roep, B. O. (2015) · Tijdschrift voor kindergeneeskunde · doi:10.1007/s12456-015-0004-6
Wan, X. (2013) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/43262
Dezayee, Z. M. I., Waheda, N., & Salihi, S. M. S. A. (2012) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.541773
Cloning and characterization of IA-2 specific autoantibodies in Type 1 diabetes
Johnson, C. (2016) · Research Portal (King's College London)
Biopsy of the pancreas: the predictive value and therapeutic impact on autoimmune diabetes
Nassar, W., & Mostafa, M. A. (2015) · The Egyptian Journal of Internal Medicine · doi:10.4103/1110-7782.159449
Autoantibodies in Autoimmune Polyendocrine Syndrome
Lupi, I., Brancatella, A., & Caturegli, P. (2019) · Endocrinology · doi:10.1007/978-3-319-73082-0_4-1
The Role of Chromosomal Region 16p13.13 in Type 1 Diabetes
Tomlinson, M. (2013) · doi:10.18130/v3n519 · Cited by 1
Khan, S. A., & Sujanani, S. (2022) · Journal of Maine Medical Center · doi:10.46804/2641-2225.1100
Skyler, J. S. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_15 · Cited by 1
Self-citationCurrent literature in diabetes
(2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1021
Inflammatory Pathways Linked to β Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_30
Autoantibodies in Autoimmune Polyendocrine Syndrome
Lupi, I., Brancatella, A., & Caturegli, P. (2021) · Endocrinology · doi:10.1007/978-3-319-89497-3_4
The Story of Diabetes and its Causes
Malboosbaf, R., & Hatami, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815196535123010004
Role of CD169 macrophages in cellular adaptive immune responses
Mauvais, F. (2016) · theses.fr (ABES) · doi:10.70675/a63cfe0cza36bz4b48z8a34zf880c078dc68
Étude de la réponse des cellules endocrines du pancréas à l'inflammation
Burghgrave, M. D. (2023) · theses.fr (ABES) · doi:10.70675/144236fdz5433z409dzac0cz4633fb7195bd
Diagnosis and Classification/Pathogenesis
(2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch01
Aspects of Sex Differences in Type 1 Diabetes
Tojjar, J. (2024) · Lund University Publications (Lund University)
Masala, S. (2012) · UnissResearch (Università degli Studi di Sassari)
Autoantigens and Insulin Receptor in Type 1 Diabetes
Nandedkar, N. D. (2019) · OhioLink ETD Center (Ohio Library and Information Network)
Usero, L., & Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, D. F. I. D. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
Carré, A. (2022) · theses.fr (ABES) · doi:10.70675/28c85b2dz490az44c1zbbc4z061ea62b1e33
Saschenbrecker, S., Muigg, N., Klemens, O., & Klemens, J. M. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0014295
“…instead of the standard cut-off (10 RU/mL). https://doi.org/10.1371/journal.pntd.0014295.t003 are widely recognized indicators of recent infection [30] and are commonly applied in epidemiological studies and retrospective case confirmation, especially when molecular or antigen detection methods…”
InfluentialMarqueurs diagnostiques du diabète de type 1 en 2026 et stratégie de dépistage précoce
Berger, A.-E., & Gonçalves, D. (2026) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(26)76659-4
Genetic and non-genetic influences on birth weight and type 2 diabetes
WEDEKIND, L. E. (2022) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-zbzo7yrkn
Gil-Poch, E. (2025) · Institutional Repository University of Extremadura (University of Extremadura)
Gut microbiota–host immune interactions in type 1 diabetes risk and response to immunotherapy
Xie, Q. Y., & Danska, J. S. (2026) · Gut Microbiology · doi:10.1016/j.gutmic.2026.100023
Tandel, D., Hinton, B., Cortez, F. D. J., Seftel, D., Robinson, P., & Tsai, C.-T. (2024) · doi:10.3389/fendo.2024.1340436.s001
Chapitre 15 – Le diabète de type 1
Wémeau, J.-L. (2014) · doi:10.1016/b978-2-294-71584-6.00015-5 · Cited by 1
Metadata
- Authors
- Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., & for the Diabetes Prevention Trial–Type 1 Study Group
- Affiliations
- Joslin Diabetes Center (US)
- University of Miami (US)
- University of South Florida (US)
- Barbara Davis Center for Childhood Diabetes, Denver, Colorado;
- University of Washington (US)
- University of Florida Health (US)
- Corresponding author
- Sosenko, Jay M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-09-09
- Volume
- 32
- Issue
- 12
- Pages
- 2269-2274
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2782989
- OpenAlex
- W2164736991
- Cited by
- 260
- References
- 31
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 9 · 2023: 8 · 2022: 18 · 2021: 17 · 2020: 9 · 2019: 18 · 2018: 11 · 2017: 14 · 2016: 20 · 2015: 26 · 2014: 24 · 2013: 24 · 2012: 25
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Joslin Diabetes Center
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK117009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, islet autoantibodies, GAD65 antibodies, autoantibody titers, diabetes prediction, prevention trials
- MeSH terms
- Autoantibodies, Diabetes Mellitus, Type 1, Glutamate Decarboxylase, Humans, Islets of Langerhans, Predictive Value of Tests, Prospective Studies, Surveys and Questionnaires, Cohort Studies, Receptor-Like Protein Tyrosine Phosphatases, Class 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.